MorphoSys AG
F:MOR2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MorphoSys AG
F:MOR2
|
DE |
|
Grieg Seafood ASA
F:GR8
|
NO |
|
Etteplan Oyj
F:EPL
|
FI |
|
P
|
PPL Corp
SWB:PP9
|
US |
|
Corning Inc
NYSE:GLW
|
US |
|
P
|
PPL Corp
F:PP9
|
US |
|
P
|
P10 Inc
F:AC3
|
US |
|
C
|
Commercial Vehicle Group Inc
F:FDU
|
US |
|
Williams Companies Inc
NYSE:WMB
|
US |
|
Prologis Inc
NYSE:PLD
|
US |
|
Ascencio SCA
F:ZYY
|
BE |
|
M
|
Medifast Inc
F:MDF
|
US |
|
E
|
Emerald Resources NL
OTC:EOGSF
|
AU |
|
Transcat Inc
F:TR8
|
US |
|
Z
|
Zimmer Biomet Holdings Inc
XMUN:ZIM
|
US |
|
H
|
Heartland Group Holdings Ltd
F:73X
|
NZ |
|
Hartford Financial Services Group Inc
NYSE:HIG
|
US |
Wall St Price Targets
MOR2 Price Targets Summary
MorphoSys AG
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOR2's stock price target?
Not Available
MOR2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for MorphoSys AG?
Projected CAGR
24%
Over the last 8 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 24%.